Search

Your search keyword '"Genentech Inc. -- Forecasts and trends"' showing total 132 results

Search Constraints

Start Over You searched for: Descriptor "Genentech Inc. -- Forecasts and trends" Remove constraint Descriptor: "Genentech Inc. -- Forecasts and trends"
132 results on '"Genentech Inc. -- Forecasts and trends"'

Search Results

1. SSc-ILD Market on Track for Major Expansion by 2034, According to DelveInsight | MERCK, GlaxoSmithKline, Genentech, Acceleron, Prometheus Biosciences, Boehringer Ingelheim, Actelion, Hopital Claude

2. Immune Thrombocytopenia Purpura Market to Expand Significantly by 2034, States DelveInsight Report | Biotest, Argenx, Sanofi, Principia Biopharma, Rigel Pharma, Principia Biopharma, GlaxoSmithKline

3. Vascular Malformations Market to Grow Substantially by 2034, Assesses DelveInsight | Key Companies - ARTham Therapeutics, Neurelis, Protara Therapeutics, Recursion, Genentech, Vascular Therapies, Palvella Therapeutics

4. HER2-Negative Breast Cancer Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, Epidemiology and Forecast by DelveInsight | Genentech, Inc., AstraZeneca, Novartis

5. Multiple Myeloma Market Trends & Forecasts 2032 | Drug Pipeline, FDA Approvals, and companies by DelveInsight | GSK, BMS, Bluebird bio, Oncopeptides AB, Secura Bio, Amgen, Takeda, Sanofi, Janssen

6. Choroidal Neovascularization Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Abbvie, Sylentis, Ixoberogene soroparvovec, Novartis, Roche

7. CD-20 Market to Witness Significant Growth During the Study Period (2019-2032), Assesses DelveInsight | Major Players - TG Therapeutics, Genentech (Roche), Genmab, Abbvie, Regeneron

8. Relapsing|Refractory Multiple Myeloma Market to Observe Stupendous Growth by 2032, Estimates DelveInsight | Leading Companies - Bristol-Myers Squibb, Allogene Therapeutics, Genentech, Pfizer, Ionis Pharmaceuticals, AbbVie, Amgen

9. Relapsing/Refractory Multiple Myeloma Market to Observe Stupendous Growth by 2032, Estimates DelveInsight | Leading Companies - Bristol-Myers Squibb, Allogene Therapeutics, Genentech, Pfizer, Ionis Pharmaceuticals, AbbVie, Amgen

10. Arteriovenous Malformations Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Genentech, Micro Therapeutics Inc., Shire, Eisai Co., Ltd

11. Systemic Sclerosis-associated Interstitial Lung Disease Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | MERCK, GSK, Genentech

12. Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics

13. Cutaneous Squamous Cell Carcinoma Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Key Players - Genentech, Incyte, Boehringer Ingelheim, Merck, Regeneron, Sanofi, Morphogenesis, NeoImmuneTech

14. Chronic Obstructive Pulmonary Disease Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron

15. Choroidal Neovascularization Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | Abbvie, Sylentis, Ixoberogene soroparvovec, Novartis, Hoffmann-La Roche

16. Acute Lymphocytic Leukemia Market to Accelerate Substantially by 2032, Assesses DelveInsight | Key Companies in the Market - Beam, Pfizer, Genentech, AbbVie, Fate, Roche, Ascentage, Janssen, Jazz, ADC, Kymera, Syndax, ImmunoGen

17. Cervical Cancer Market Size is Likely to Increase, Examines DelveInsight | Key Companies in the Market - Gilead, Roche, Genentech, Iovance, Bristol-Myers Squibb, Exelixis, Xencor, Merck, EMD Serono, Pfizer, Fusion, AstraZeneca

18. Cervical Cancer Market Size is Likely to Increase, Examines DelveInsight | Key Companies in the Market - Gilead, Roche, Genentech, Iovance, Bristol-Myers Squibb, Exelixis, Xencor, Merck, EMD Serono, Pfizer, Fusion, AstraZeneca

19. Hemophilia Market to Proliferate Immensly, Predicts DelveInsight | Key Companies to Look Out for - Pfizer, Sanofi, CSL Behring, Freeline, Genentech, Shire, Spark, Novo Nordisk, Sangamo, UBI, uniQure

20. Ovarian Clear Cell Carcinoma Market expected to rise, Genentech, GlaxoSmithKline, AstraZeneca, Clinigen Group, Novartis, Clovis Oncology, Ortho Biotech, Bristol-Myers Squibb, expected to drive market

21. Cutaneous Squamous Cell Carcinoma Market expected to rise, Incyte Corporation, Shanghai Henlius Biotech, Novartis, Rakuten Medical, Morphogenesis, Genentech, Berg Pharma, I-MAB Biopharma, Roche

22. Basal Cell Carcinoma Market to Observe Impressive Growth During the Forecast Period (2022-2032), Evaluates DelveInsight | Novartis, MEDA Pharma, Genentech, Inc., Galderma R&D, Hoffmann-La Roche

23. Global Protein Therapeutics Market Report 2023: Development of Plasma Derived Therapies Drives Growth

24. Sinusitis Market to Register Stunning Growth, Estimates DelveInsight | Key Players in the Market - Optinose, GeneOne Life Science, Lyra, Sanofi, Regeneron, Genentech, AstraZeneca, Sanofi, Bayer, Pfizer

25. Metastatic Renal Cell Carcinoma Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2022-2032), Analyzes DelveInsight | Key Companies - AstraZeneca, Genentech, Sumitomo

26. 30+ Active Companies working to develop 35+ Pipeline Therapies for Food Allergy Treatment Landscape | Major Companies - Merck, Genentech, Novartis, and Others

27. Endometrial Cancer Market Growing Significantly | AstraZeneca, Karyopharm, Evergreen therapeutics, ImmunoGen, Inc., Merck, Tesaro, Inc., Abbott, Roche, Chimerix, Bayer, ImmunoGen, Inc., Incyte, Eli Lilly, Gilead, Genentech Expected to Boost

28. Global Oncology Drugs Market Size & Analysis

29. Lupus Nephritis Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies - Hoffmann-La Roche, Genentech, Inc., Astrazeneca, Equillium

30. Diabetic Retinopathy Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Key Companies - Genentech, Inc., Regeneron Pharmaceuticals

31. Antiglaucoma Drugs Global Market Report 2023

32. Global Genitourinary Drugs Market Report 2022 to 2027: Featuring Allergan, Antares Pharma, Bayer and Novartis Among Others

33. Antiglaucoma Drugs Global Market Report 2023

34. Genitourinary Drugs Global Market 2022: Sector to Reach $35.5 Billion by 2027 at a CAGR of 2.01%

35. Genitourinary Drugs Global Market 2022: Sector to Reach $35.5 Billion by 2027 at a CAGR of 2.01%

36. Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) Market Report (2022 to 2030) - Pfizer Inc., Novartis AG, Genentech, Inc., GlaxoSmithKline Plc. and LFB Biomedicaments

37. Global Hemophilia Treatment Market Report 2022 to 2030 - Featuring Ferring, Kedrion, Octapharma and Novo Nordis Among Others

38. Worldwide Hemophilia Treatment Industry to 2030 - by Product, Hemophilia Type and Region

39. Worldwide Hemophilia Treatment Industry to 2030 - by Product, Hemophilia Type and Region

40. Global Hemophilia Treatment Market Report 2022 to 2030 - Featuring Ferring, Kedrion, Octapharma and Novo Nordis Among Others

41. 40+ Leading Thyroid Cancer Pipeline Companies are working to improve the treatment landscape

42. Food Allergy Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

43. Spinal Muscular Atrophy Treatment Market Worth $18.0 Billion by 2030: Grand View Research, Inc

44. Thyroid Cancer Pipeline Landscape Analysis: 40+ Key Players & 40+ Pipeline Drugs

45. Lupus Nephritis Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies - Hoffmann-La Roche, Genentech, Astrazeneca, Equillium, Novartis

46. Global Patient Access/Front-end RCM Solutions Market Analysis Report 2022: Growing Focus on Integration Platform as a Service (IPaaS) & Budgetary Constraints and Cost-Cutting Measures in Europe

47. USD 1.31 Bn growth for Urticaria Drugs Market through 2026: Analysing growth for Pharmaceuticals - Technavio

48. Global Acquired von Willebrand Disease (AvWD) Treatment Market Report 2022-2030 Featuring Key Players - Novo Nordisk A|S, Genentech, Inc., F. Hoffman-La Roche AG, Sanofi SA

49. Global Acquired von Willebrand Disease (AvWD) Treatment Market Report 2022-2030 Featuring Key Players - Novo Nordisk A/S, Genentech, Inc., F. Hoffman-La Roche AG, Sanofi SA

50. $7.9 Billion Worldwide Human Growth Hormone Industry to 2027 - Featuring Genentech, Ipsen, Merck and Novartis Among Others

Catalog

Books, media, physical & digital resources